Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a specific type of heart device (called an ICD or CRT-D) newly implanted within the last year, where the device includes atrial sensing and a remote home monitoring system.
- People with a documented diagnosis of heart failure, whether caused by blocked arteries or another heart condition.
- People whose heart was pumping at 35% or less of its normal capacity, and who were classified as moderate heart failure (Class II or III), at the time their device was implanted.
- People whose heart is beating in a normal, regular rhythm (called sinus rhythm).
- People aged 18 years or older.
- People who have signed a consent form agreeing to take part in the study.
Who may not be able to join:
- People whose implanted device was a replacement or upgrade of an older device, rather than a first-time implant.
- People who received their heart device more than one year ago.
- People who already have a specific monitoring feature called HeartInsight switched on at the time of enrolment.
- People with a permanent or long-term irregular heart rhythm in the upper chambers of the heart (called atrial fibrillation).
- People with a condition affecting the heart's natural pacemaker that means they need pacing support in the upper heart chambers.
- People classified as severe heart failure (Class IV) at the time of enrolment.
- People who have planned heart surgery scheduled within three months of joining the study.
- People whose life expectancy is less than one year.
- People without a stable home address or who do not have adequate mobile network coverage at home to support the remote monitoring system.
- People who are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dario Gregori, Full Professor, Unit of Biostatistics, Epidemiology and Public Health - UBEP, University of Padova
Phone: +39 049 8275384
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Actionable alerts
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.